Primidone Tablets Recalled for Cross-Contamination with Acemetacin
Golden State Medical Supply Inc. is recalling Primidone 250 mg tablets due to cross-contamination with trace amounts of Acemetacin API. The affected lots are distributed nationwide.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: FDA Class III recalls are by definition unlikely to cause adverse health consequences. The source text reports only trace contamination with no reported illnesses or injuries.
Plain-English summary
Golden State Medical Supply Inc. is recalling Primidone (Primidone Tablets, USP, 250 mg) due to cross-contamination with trace amounts of Acemetacin API. The recalled product is a prescription medication used as an anti-epileptic agent.
The recall affects 1,620 bottles distributed nationwide. The affected lots are: Lot #GS067909 (Exp 4/30/2028) and Lot #GS068646 (Exp 8/31/2026), NDC 51407-638-01.
Patients taking the affected medication should consult their healthcare provider or pharmacist immediately. Do not discontinue use without medical guidance, as sudden discontinuation of anti-epileptic medication can be harmful.
The recalled product
- Product
- PRIMIDONE (PRIMIDONE)
- Brand
- PRIMIDONE
- Manufacturer
- Golden State Medical Supply Inc.
- Hazard
- cross-contamination
- mis-labeling
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: GS067909
- Exp 4/30/2028
- GS068646
- Exp 8/31/2026
Distribution
Distributed nationwide across the United States.